Related Experiment Videos
MycN sensitizes neuroblastoma cells for drug-triggered apoptosis
Background:
Amplification of the MYCN gene is found in a large proportion of neuroblastomas and is associated with a poor prognosis.
Procedure:
To investigate the effect of ectopic MycN expression on the susceptibility of neuroblastoma cells to cytotoxic drugs, we used a human neuroblastoma cell line with tetracycline-controlled expression of MycN.
Results:
Neither conditional expression of MycN alone nor low drug concentrations induced apoptosis. However, MycN and cytotoxic drugs cooperated to induce cell death. Apoptosis triggered by MycN and doxorubicin was mediated by cleavage of caspases and involved activation of the CD95 system. MycN overexpression and cytotoxic drugs also synergized to induce p53 and Bax protein expression and to trigger mitochondrial permeability transition and cytochrome c release.
Conclusion:
In that amplification of MYCN is considered an adverse prognostic factor, these findings suggest that dysfunctions in apoptosis pathways may be a mechanism by which MycN-induced apoptosis of neuroblastoma cells is inhibited.
Insights
MYCN amplification in neuroblastoma can inhibit apoptosis, making cancer cells resistant to drugs. This study shows MycN and chemotherapy synergize to induce cancer cell death, offering potential therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MYCN gene amplification is prevalent in neuroblastoma.
- MYCN amplification is linked to poor prognosis in neuroblastoma patients.
Purpose of the Study:
- To investigate the impact of ectopic MycN expression on neuroblastoma cell sensitivity to cytotoxic drugs.
- To understand the mechanisms of MycN-mediated drug resistance in neuroblastoma.
Main Methods:
- Utilized a human neuroblastoma cell line with tetracycline-controlled MycN expression.
- Assessed apoptosis induction and cell death in response to MycN expression and cytotoxic drugs.
Main Results:
- MycN overexpression and cytotoxic drugs synergistically induced neuroblastoma cell death.
- Apoptosis involved caspase cleavage, CD95 system activation, p53 and Bax upregulation, and mitochondrial pathway activation.
- Neither MycN alone nor low drug concentrations induced apoptosis.
Conclusions:
- Dysregulation of apoptosis pathways may contribute to MycN-driven drug resistance in neuroblastoma.
- Targeting apoptosis pathways could be a therapeutic strategy for MYCN-amplified neuroblastomas.